Safety and Efficacy of Rasagiline in Restless Legs Syndrome.
Phase of Trial: Phase II/III
Latest Information Update: 08 Feb 2013
At a glance
- Drugs Rasagiline (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Acronyms RAS-RLS
- 08 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 27 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Sep 2010 New trial record